Patents by Inventor Tapio Korkolainen

Tapio Korkolainen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF BETA-LACTAMASE
    Publication number: 20090311234
    Abstract: Class A beta-lactamase may be used for reducing side-effects in the intestine associated with antibiotic therapy with a combination of beta-lactam antibiotic and beta-lactamase inhibitor.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 17, 2009
    Applicant: IPSAT Therapies Oy
    Inventors: Pertti Koski, Tapio Korkolainen, Kristiina Raatesalmi
  • Pharmacologically active catechol derivatives
    Patent number: 6121303
    Abstract: A compound of formula I ##STR1## wherein R.sub.1 is nitro, halogeno or cyano group and R.sub.2 is a group selected from ##STR2## wherein Y and Z are independently oxygen, sulfur or NR, wherein R is hydrogen, straight or branched C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, phenylC.sub.1-8 alkyl or phenyl group and X.sub.1 and X.sub.2 are NR, where R is hydrogen, straight or branched C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, phenylC.sub.1-8 alkyl or phenyl group, or a pharmaceutically acceptable salt or ester thereof. Pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: September 19, 2000
    Assignee: Orion-yhtyma Oy
    Inventors: Reijo Backstrom, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen
  • Pharmacologically active catechol derivatives
    Patent number: 5889037
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 30, 1999
    Assignee: Orion-yhtyma Oy
    Inventors: Reijo Backstrom, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen
  • Pharmacologically active catechol derivatives
    Patent number: 5614541
    Abstract: New catechol derivatives and pharmaceutically acceptable salts and esters thereof useful as pharmaceutical antioxidants are disclosed. Cellular damage by oxygen derived radicals is a significant factor in heart disease, rheumatoid arthritis, cancer, inflammatory disease, transplant rejection reactions and ischemia.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: March 25, 1997
    Assignee: Orion-yhtym a Oy
    Inventors: Reijo B ackstr om, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen
  • Pharmacologically active catechol derivatives
    Patent number: 5362733
    Abstract: Compounds of formula(I) ##STR1## wherein R.sub.1 is nitro, halo, cyano and R.sub.2 is a group selected from ##STR2## wherein Y is oxygen or sulfur; X.sub.1 is NR wherein R is hydrogen, C.sub.1-8 alkyl or phenyl and pharmaceutically acceptable salts thereof are useful in the prevention or treatment of tissue damage induced by lipid peroxidation.
    Type: Grant
    Filed: October 23, 1992
    Date of Patent: November 8, 1994
    Assignee: Orion-yhtyma Oy
    Inventors: Reijo Backstrom, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen